Q.Discuss with your teacher what does 'a suitable gene' means, in the context of DNA vaccines.
You're viewing a preview — the full solution, concept, methods & PYQ mapping are locked.
Start your 14-day free trial to unlock the full solution →In DNA vaccines, a 'suitable gene' refers to a specific segment of DNA from a pathogen that encodes an antigen capable of eliciting a protective immune response in the host without causing disease.
DNA vaccines represent a revolutionary approach in vaccinology, moving beyond traditional methods that use weakened or killed pathogens, or even just their protein components. Instead, a DNA vaccine directly introduces a piece of genetic material – a gene – into the host's cells. The fundamental idea is to turn the host's own cellular machinery into a mini-factory for producing the pathogen's antigen. This antigen then triggers an immune response, preparing the body to fight off a real infection.
In this context, the term 'a suitable gene' is absolutely critical, as the success and safety of the entire vaccine hinge on this specific genetic blueprint. It is not just any gene; it must possess very particular characteristics to be effective and harmless.
Here's what makes a gene 'suitable' for a DNA vaccine:
-
Origin from the Pathogen: The gene must originate from the disease-causing organism (e.g., a virus, bacterium, or parasite) against which we want to develop immunity. It acts as a molecular identifier of the threat.
-
Encoding an Antigen: The primary function of this gene is to carry the instructions for making a specific protein, or a part of a protein, that is recognized as 'foreign' by the host's immune system. This protein is called an antigen. For instance, in the case of a virus, this might be a gene for a surface protein like a spike protein or an envelope protein. For bacteria, it could be a gene for a surface adhesion protein or a modified toxin.
-
Immunogenicity: The antigen produced from this gene must be capable of eliciting a strong and protective immune response. This means it should stimulate both the production of antibodies (humoral immunity) and the activation of specific T-cells (cellular immunity), which are crucial for long-term protection. The immune system must 'learn' to recognize and neutralize this antigen efficiently.
-
Non-pathogenicity: This is a paramount safety requirement. The gene itself, and the antigen it produces, must not be capable of causing the disease. We are only using a harmless fragment of the pathogen's genetic information, not the entire pathogen or its virulence factors. This ensures that the vaccine cannot inadvertently cause the illness it is designed to prevent.
ImportantThe gene chosen for a DNA vaccine must encode an antigen that is highly immunogenic but completely non-pathogenic, ensuring safety while effectively priming the immune system. …
Unlock everything free for 14 days
- Full step-by-step solutions
- Concept-first explanations
- Methods, shortcuts & mistakes
- PYQ mapping + timed mock tests
Full access for 14 days. No credit card required.